Skip to menu Skip to content Skip to footer

2008

Conference Publication

Chronic kidney disease following orthotopic liver transplantion

Frazier, J., Lipka, G., Johnson, D., Hawley, C., Campbell, S., Mudge, D., Van Eps, C., Isbel, N. and Macdonald, G. (2008). Chronic kidney disease following orthotopic liver transplantion. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6–10 September 2008. Richmond, VIC, Australia: Wiley-Blackwell.

Chronic kidney disease following orthotopic liver transplantion

2008

Conference Publication

Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease

Hickman, I. J., Sullivan, C. M., Flight, S., Campbell, C., Crawford, D. H., Masci, P. P., O'Moore-Sullivan, T. M., Prins, J. B. and Macdonald, G. A. (2008). Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease. 16th European Congress on Obesity, Geneva, Switzerland, 14-17 May 2008. LONDON: NATURE PUBLISHING GROUP.

Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease

2008

Conference Publication

What do GPS in QLD really think about community based HCV prescribing?

Martin, J., Ferndale, C., Hayllar, J., Lambert, S., McGrath, F., Page, A., Reiner, R., Reuter, B., Sexton, J., White, S., Wittmann, J. and Macdonald, G. (2008). What do GPS in QLD really think about community based HCV prescribing?. 6th Australasian Viral Hepatitis Conference, Brisbane, Queensland, Australia, 20–22 October 2008. Carlton South, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05655_2.x

What do GPS in QLD really think about community based HCV prescribing?

2008

Conference Publication

Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores

Williams, E.J., Dixon, J., Powell, L.W. and Macdonald, G.A. (2008). Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April 2008. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(08)60984-8

Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores

2008

Conference Publication

The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease

Nguyen, T., Murphy, T. L., Lipka, G., Fletcher, L. M. and Macdonald, G. A. (2008). The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease. Australian Gastroenterology Week, Brisbane, QLD, Australia, 22-25 October 2008. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease

2008

Conference Publication

The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease

Nguyen, Thien, Murphy, Therese L., Lipka, Geraldine, Fletcher, Linda M. and Macdonald, Graeme A. (2008). The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, United States, 31 October-4 November 2008. Hoboken, NJ, United States: Wiley Interscience. doi: 10.1002/hep.22645

The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease

2007

Conference Publication

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study

Sharman, J., Holland, D., Kostner, K. M., Fairweather, H., Macdonald, G. A. and Marwick, T. H. (2007). The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study. European Society of Cardiology Annual Scientific Meeting, Vienna, Austria, 1-5 September, 2007. London ; New York: Oxford University Press.

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study

2007

Conference Publication

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study

Sharman, J. E., Holland, D., Kostner, K., Fairweather, H., Macdonald G. and Marwick T. H. (2007). The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study. Cardiac Society of Aust and NZ Annual Scientific Meeting, Christchurch, New Zealand, 9-12 August, 2007. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1016/j.hlc.2007.06.420

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study

2006

Conference Publication

The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells

Beaton, M. D., Wilkins, S. J., Frazer, D. M., Whitehead, J. P., Moffitt, J. H., Macdonald, G. A., Powell, L. W. and Anderson, G. J. (2006). The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell.

The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells

2006

Conference Publication

Causes of raised liver enzymes in a diabetic clinic

Hickman, I. J., Russell, A. W. and Macdonald, G. A. (2006). Causes of raised liver enzymes in a diabetic clinic. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell.

Causes of raised liver enzymes in a diabetic clinic

2006

Conference Publication

Serum adiponectin is increased in HFE-/- mice fed alcohol

Bridle, K. R., Murphy, T. L., Anderson, G. J., Macdonald, G. A., Crawford, D. H. G. and Fletcher, L. M. (2006). Serum adiponectin is increased in HFE-/- mice fed alcohol. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Serum adiponectin is increased in HFE-/- mice fed alcohol

2005

Conference Publication

Optimising conditions for assessing glucose output from isolated rat hepatocytes in response to insulin

Stephenson, M. D., Bridle, K. R., Whitehead, J. P. and Macdonald, G. A. (2005). Optimising conditions for assessing glucose output from isolated rat hepatocytes in response to insulin. Australian Gastroenterology Week 2005, Brisbane, Qld, Australia, 19-22 October, 2005. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2005.04091_4.x

Optimising conditions for assessing glucose output from isolated rat hepatocytes in response to insulin

2005

Conference Publication

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

Anderson, Greg, Frazer, David M., Bridle, Kim R., Macdonald, Graeme A., Smith, Jeffrey L., Turlin, Bruno, Subramaniam, Nathan, Crawford, Darrell H., Powell, Lawrie W. and Ramm, Grant A. (2005). Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease. 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, 10-13 December, 2005. Washington, D.C., USA: American Society of Hematology.

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

2005

Conference Publication

Presence of the metabolic syndrome is associated with reduced adiponectin levels and liver dysfunction in patients with type 2 diabetes

Hickman, Ingrid J., Prins, Johannes B., Whitehead, Jonathon P. and Macdonald, Graeme A. (2005). Presence of the metabolic syndrome is associated with reduced adiponectin levels and liver dysfunction in patients with type 2 diabetes. 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases,, San Francisco, CA, 11-15 November, 2005. Hoboken, NJ: Wiley Interscience. doi: 10.1002/hep.20927

Presence of the metabolic syndrome is associated with reduced adiponectin levels and liver dysfunction in patients with type 2 diabetes

2004

Conference Publication

The site and role of post-translational modifications in the oligiomerisation and secretion of adiponectin

Richards, Ayanthi, Prins, John B., Whitehead, Jon and MacDonald, Graeme A. (2004). The site and role of post-translational modifications in the oligiomerisation and secretion of adiponectin. 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, 29 October - 2 November, 2004. Hoboken, NJ: Wiley InterScience.

The site and role of post-translational modifications in the oligiomerisation and secretion of adiponectin

2004

Conference Publication

Symptom prevalence and temporal clustering of symptoms in people living with chronic hepatitis C infection

Lang, C. A., Battistutta, D., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2004). Symptom prevalence and temporal clustering of symptoms in people living with chronic hepatitis C infection. 39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Germany, 14-18 April, 2004. Copenhagen, Denmark: Elesvier. doi: 10.1016/S0168-8278(04)90485-0

Symptom prevalence and temporal clustering of symptoms in people living with chronic hepatitis C infection

2004

Conference Publication

Impairments in quality of life due to symptom clusters in people living with chronic hepatitis C infection are poorly identified by the Short Form-36 (SF-36)

Lang, C. A., Battistutta, D., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2004). Impairments in quality of life due to symptom clusters in people living with chronic hepatitis C infection are poorly identified by the Short Form-36 (SF-36). 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, Massachusetts, 29 October - 2 November, 2004. Hoboken, NJ: Wiley Interscience.

Impairments in quality of life due to symptom clusters in people living with chronic hepatitis C infection are poorly identified by the Short Form-36 (SF-36)

2002

Conference Publication

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

Hickman, Ingrid, Clouston, Andrew, Ash, Susan, MacDonald, Graeme, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction improves biochemistry and histology in patients with chronic hepatitis C. Nutrition Week: A Scientific and Clinical Forum and Exposition, Bethesda, MD, 2002. Bethesda, MD: American Society for Nutrition.

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

2002

Conference Publication

Quality of life in hepatitis C infection: A profile of symptoms

Macdonald, G. A., Lang, C., Garrett, L., Cook, M., Williams, H., Cooksley, G. and Dunne, M. P. (2002). Quality of life in hepatitis C infection: A profile of symptoms. 53rd Annual Meeting of the Association for the Study of Liver Diseases (AASLD), Boston, MA, United States, 1-5 November, 2002. Hoboken, NJ, United States: Wiley Interscience.

Quality of life in hepatitis C infection: A profile of symptoms

2002

Conference Publication

Weight reduction in patients with chronic HCV reduces circulating insulin levels

Hickman, Ingrid, Clouston, Andrew, Macdonald, Graeme, Ash, Susan, Prins, John, Purdie, David, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction in patients with chronic HCV reduces circulating insulin levels. -, Milan, Italy, April 18th, 2002. Ireland Ltd.: Elsevier Science. doi: 10.1016/S0168-8278(02)80921-7

Weight reduction in patients with chronic HCV reduces circulating insulin levels